详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. [2]Indore Institute of Pharmacy, IIST Campus, Rau, Indore-453331, Madhya Pradesh, India. [3]Chitkara College of Pharmacy, Chitkara University, Rajpura-Punjab, India-140401. [4]MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be) University, Mullana-Ambala, Haryana, India. [5]Discipline of Pharmacy Graduate School of Health Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine (ARCCIM) University of Technology Sydney, Sydney, Australia. [6]Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, Vile Parle (W), Mumbai-400 056, India. [7]School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab-144411, India.

出处：

DOI：

ISSN：

关键词： Nanomedicine nanotechnology cancer apoptosis cell proliferation drug delivery

摘要：

Nanomedicine's application of nanotechnology in medicine holds tremendous potential for diagnosing and treating life-threatening diseases such as cancer. Unlike conventional therapies, nanomedicine offers a promising strategy to enhance clinical outcomes while minimizing severe side effects. The principle of drug targeting enables specific delivery of therapeutic agents to their intended sites, making it a more precise and effective therapy. Combination strategies, such as the co-delivery of chemotherapeutic drugs with nucleic acids or receptor-specific molecules, are being employed to enhance therapeutic outcomes. Nanocarriers and drug delivery systems designed using these approaches offer resourceful co-delivery of therapeutic agents for anticancer therapy. Targeted drug delivery via nanotechnology-based techniques has become an urgent need and has shown significant improvements in therapeutic implications, pharmacokinetics, specificity, reduced toxicity, and biocompatibility. This review discusses the extrapolation of nanomaterials for developing innovative and novel drug delivery systems for effective anticancer therapy. Additionally, we explore the role of nanotechnology-based concepts in drug delivery research.Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版中科院分区表Review为是的期刊

：

大类 | 4 区医学

小类 | 3 区生化与分子生物学 3 区药物化学 3 区药学

最新[2023]版

：

大类 | 4 区医学

小类 | 3 区生化与分子生物学 3 区药物化学 3 区药学

第一作者：

第一作者机构： [1]Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China. [2]Indore Institute of Pharmacy, IIST Campus, Rau, Indore-453331, Madhya Pradesh, India.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery [2]Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease. [3]Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy. [4]Nanotechnology based gas delivery system: a "green" strategy for cancer diagnosis and treatment [5]Progress and application of intelligent nanomedicine in urinary system tumors [6]Promising Nanomedicines of Shikonin for Cancer Therapy [7]Preparation and application of pH-responsive drug delivery systems. [8]Nanomedicine for urologic cancers: diagnosis and management. [9]RSPH14 regulates the proliferation, cell cycle progression, and apoptosis of non-small cell lung cancer cells [10]Artificial intelligence aids in development of nanomedicines for cancer management